|
|
|
| Treatment Regimens for TB |
||
| Resistant Only to INH |
||
|
|
|
|
|
|
|
|
|
|
| HIV-Negative Persons |
|||||||||
| • | Carefully
supervise and manage treatment to avoid |
||||||||
| development of MDR TB |
|||||||||
| • | Discontinue
INH and continue RIF, PZA, and EMB |
||||||||
| or SM for the entire 6 months |
|||||||||
| • | Or,
treat with RIF and EMB for 12 months |
||||||||
| HIV-Positive Persons |
|||||||||
| • | Regimen
should consist of a rifamycin, PZA, and EMB |
||||||||